Case Investigations

Enochian BioSciences, Inc.

May 26, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Enochian BioSciences Inc. (“Enochian” or the “Company”) (Nasdaq: ENOB), a company that purports to be biotechnology company.

Inotiv, Inc.

May 25, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inotiv Inc. ("Inotiv” or the "Company") (NASDAQ: NOTV).

Singularity Future Technology Ltd

May 17, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Singularity Future Technology Ltd ("Singularity” or the "Company") (NASDAQ: SGLY).

IonQ

May 6, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of IonQ ("IonQ or the "Company") (IONQ: NYSE), a company that was formed by the September 2021 business combination with dMY Technology Group, Inc. III (“dMY III”) (NYSE: DMYI), a publicly traded special acquisition company.

Data Breach Potentially Compromises the Personal Data of Over 1 Million Students From at Least New York, California, Colorado and Connecticut

New York, NY – May 11, 2022  - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of past and present New York City public school students, as well as students from schools in other states, whose personal data may have been compromised due to a data breach at an outside vendor to which the schools provided student data.

Lilium N.V. f/k/a Qell Acquisition Corp.

May 4 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Lilium N.V. f/k/a Qell Acquisition Corp. (“Lilium” or the “Company”) (NASDAQ: LILM; QELL). A complaint has been filed on behalf of investors who purchased or otherwise acquired  Lilium securities between March 30.2021 through March 14, 2022.

Teladoc Health, Inc.

April 29 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC).

Molecular Partners AG

April 29 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Molecular Partners AG ADRs ("Molecular Partners" or the "Company") (NASDAQ:MOLN).

DENTSPLY SIRONA Inc.

April 20, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY), a company that purports to be the world’s largest manufacturer of professional dental products and technologies.

Arqit Quantum, Inc.

April 19, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Arqit Quantum Inc. (“Arqit” or the “Company”) (Nasdaq: ARQQ, ARQQW).  Arqit is a cybersecurity company that purports to be developing quantum encryption technology to secure against cyber attacks.

TransUnion

April 13, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of TransUnion (NYSE: TRU).

Embark Technology, Inc.

April 12, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Embark Technology, Inc. f/k/a Northern Genesis Acquisition Corp. (“Embark” or the “Company”) (NASDAQ: EMBK), a company that develops self-driving solutions for the trucking industry in the U.S.  A complaint has been filed on behalf of investors who purchased or otherwise acquired Embark securities stock between January 12, 2021 and January 5, 2022.

Lucid Group, Inc.

April 11, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Lucid Group, Inc. (“Lucid” or the “Company”) (NASDAQ: LCID), a company that designs, engineers, builds, and sells luxury electric vehicles.  A complaint has been filed on behalf of investors who purchased or otherwise acquired Lucid common stock between November 15, 2021 and February 28, 2022.

Kaleido Biosciences, Inc.

April 11, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Kaleido Biosciences, Inc. (“Kaleido Biosciences” or the “Company”) (Nasdaq: KLDO).

NeoGenomics, Inc.

March 29, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (Nasdaq: NEO), a company that operates a network of clinical laboratories providing cancer genetics diagnostic testing services.

Grab Holdings, Inc.

March 24, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Grab Holdings Limited (“Grab” or the “Company”) (NASDAQ: GRAB).  Grab purportedly offers a superapp that operates primarily across the deliveries, mobility, and digital financial services sectors in Southeast Asia.  A complaint has been filed on behalf of investors who purchased or otherwise acquired Grab securities between November 12, 2021 and March 3, 2022, inclusive (the “Class Period”).

Affirm Holdings, Inc.

March 21, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM).  A complaint has been filed on behalf of investors who purchased or otherwise acquired Affirm securities on February 10, 2022 after the Company sent a Tweet concerning its Second Quarter 2022 financial results at approximately 1:15pm EST (the “Class Period”).

Butterfly Network, Inc.

March 1, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Butterfly Network, Inc. f/k/a/ Longview Acquisition Corp. (“Butterfly” or the “Company”) (NYSE: BFLY).  A complaint has been filed on behalf of investors who purchased or otherwise acquired Butterfly securities between February 16, 2021 and November 15, 2021.

Acutus Medical, Inc.

March 1 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB).  A complaint has been filed on behalf of investors who purchased or otherwise acquired Acutus common stock between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”).

SunPower Corporation

March 2, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SunPower Corporation (“SunPower” or the “Company”) (NASDAQ: SPWR).  A complaint has been filed on behalf of investors who purchased or otherwise acquired SunPower securities between August 3, 2021 and January 20, 2022, inclusive (the “Class Period”).

Astra Space, Inc.

February 28, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Astra Space Inc. f/k/a/ Holicity Inc. (“Astra” or the “Company”) (NASDAQ: ASTR).  A complaint has been filed on behalf of investors who purchased the publicly traded securities of Astra between February 2, 2021 through December 29, 2021.

TaskUS, Inc.

January 26, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of TaskUs, Inc. (“TaskUS” or the “Company”) (NASDAQ: TASK), a company that provides outsourced digital services.